Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
9.55
-0.04 (-0.44%)
Nov 21, 2024, 1:14 PM EST - Market open
Amicus Therapeutics Employees
Amicus Therapeutics had 517 employees as of December 31, 2023. The number of employees increased by 33 or 6.82% compared to the previous year.
Employees
517
Change (1Y)
33
Growth (1Y)
6.82%
Revenue / Employee
$954,876
Profits / Employee
-$202,491
Market Cap
2.85B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Amedisys | 19,000 |
Surgery Partners | 13,500 |
Warby Parker | 3,473 |
HUTCHMED (China) | 1,988 |
Inari Medical | 1,300 |
Vericel | 314 |
Xenon Pharmaceuticals | 259 |
Merus | 229 |
FOLD News
- 8 days ago - NCLA Amicus Brief Asks Fifth Circuit to Overturn Currency Comptroller's Violation of Jury Trial Rights - GlobeNewsWire
- 15 days ago - Amicus Therapeutics, Inc. (FOLD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 20 days ago - Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024 - GlobeNewsWire
- 24 days ago - Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024 - GlobeNewsWire
- 4 weeks ago - American Citizens Abroad (ACA) joins amicus brief supporting voting by U.S. citizens overseas - GlobeNewsWire
- 4 weeks ago - 3 Attractive Biotechs With Recent Positives - Seeking Alpha
- 4 weeks ago - Amicus: Teva Settlement Clears Revenue Path Forward For Galafold - Seeking Alpha
- 5 weeks ago - Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug - Benzinga